LCM
JBIO

Lynx1 Capital Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History

Lynx1 Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,898
Closed -$4.58M – 14
2022
Q3 		$4.58M Buy
7,898
+2,425
+44% +$1.41M 4.13% 6
2022
Q2 		$2.99M Buy
5,473
+3,559
+186% +$1.95M 2.55% 9
2022
Q1 		$1.23M Buy
+1,914
New +$1.23M 1.14% 11